| 1 |
Golanov EV, Bovshik EI, Wong KK, et al. Subarachnoid hemorrhage-induced block of cerebrospinal fluid flow: role of brain coagulation factor Ⅲ (tissue factor) [J]. J Cereb Blood Flow Metab, 2018, 38(5): 793-808.
|
| 2 |
de Oliveira Manoel AL, Mansur A, Silva GS, et al. Functional outcome after poor-grade subarachnoid hemorrhage: a single-center study and systematic literature review [J]. Neurocrit Care, 2016, 25(3): 338-350.
|
| 3 |
Vivancos J, Gilo F, Frutos R, et al. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment [J]. Neurologia, 2014, 29(6): 353-370.
|
| 4 |
Jayaraman MV, Haas RA, Do HM, et al. Should CT angiography be routinely used in patients suspected of having aneurysmal subarachnoid hemorrhage? No! [J]. Radiology, 2010, 254(1): 314.
|
| 5 |
Connolly ES RabinsteinJr, , Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/Am-erican Stroke Association [J]. Stroke, 2012, 43(6): 1711-1737.
|
| 6 |
Bechan RS, van Rooij SB, Sprengers ME, et al. CT angiography versus 3D rotational angiography in patients with subarachnoid hemorrhage [J]. Neuroradiology, 2015, 57(12): 1239-1246.
|
| 7 |
Westerlaan HE, van Dijk JM, Jansen-van der Weide MC, et al. Intracranial aneurysms in patients with subarachnoid hemorrhage: CT angiography as a primary examination tool for diagnosis—systematic review and meta-analysis [J]. Radiology, 2011, 258(1): 134-145.
|
| 8 |
Dabus G, Nogueira RG. Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature [J]. Interv Neurol, 2013, 2(1): 30-51.
|
| 9 |
van Lieshout JH, Dibué-Adjei M, Cornelius JF, et al. An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage [J]. Neurosurg Rev, 2018, 41(4): 917-930.
|
| 10 |
骆众星, 李萌, 谢斯栋. 3D TOF MRA在颅内微小动脉瘤诊断中的应用效果分析 [J]. 影像研究与医学应用, 2019, 3(15): 230-231.
|
| 11 |
Cancelliere NM, Najafi M, Brina O, et al. 4D-CT angiography versus 3D-rotational angiography as the imaging modality for computational fluid dynamics of cerebral aneurysms [J]. J Neurointerv Surg, 2019. pii: neurintsurg-2019-015389. [Epub ahead of print]
|
| 12 |
Grasso G, Alafaci C, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives [J]. Surg Neurol Int, 2017, 8: 11.
|
| 13 |
Togashi K, Joffe AM, Sekhar L, et al. Randomized pilot trial of intensive management of blood pressure or volume expansion in subarachnoid hemorrhage (IMPROVES) [J]. Neurosurgery, 2014, 76(2): 125-135.
|
| 14 |
Rajajee V, Pandey AS, Williamson CA. Subarachnoid Hemorrhage and the therapy formerly known as" triple-H"-new directions [J]. World Neurosurg, 2019, 127: 500-501.
|
| 15 |
Dankbaar JW, Slooter AJ, Rinkel GJ, et al. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review [J]. Crit Care, 2010, 14(1): R23.
|
| 16 |
Harrigan MR. Hypertension may be the most important component of hyperdynamic therapy in cerebral vasospasm [J]. Crit Care, 2010, 14(3): 151.
|
| 17 |
Reynolds MR, Buckley RT, Indrakanti SS, et al. The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms [J]. J Neurosurg, 2015, 123(4): 862-871.
|
| 18 |
Carlson AP, Hänggi D, Macdonald RL, et al. Nimodipine Reappraised: An Old Drug With a Future [J]. Curr Neuropharmacol, 2019. pii: neurintsurg-2019-015389. [Epub ahead of print]
|
| 19 |
Leijenaar JF, Dorhout Mees SM, Algra A, et al. Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the M agnesium in A neurysmal S ubarachnoid H aemorrhage trial (MASH‐II) [J]. Int J Stroke, 2015, 10 Suppl A100: 108-112.
|
| 20 |
Dorhout Mees SM, Algra A, Vandertop WP, et al. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial [J]. Lancet, 2012, 380(9836): 44-49.
|
| 21 |
Wong GKC, Poon WS, Chan MT, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH) a randomized, double-blinded, placebo-controlled, multicenter phase III trial [J]. Stroke, 2010, 41(5): 921-926.
|
| 22 |
van den Bergh WM, Algra A, van der Sprenkel JW, et al. Hypomagnesemia after aneurysmal subarachnoid hemorrhage [J]. Neurosurgery, 2003, 52(2): 276-282.
|
| 23 |
Vergouwen MD, Meijers JC, Geskus RB, et al. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial [J]. J Cereb Blood Flow Metab, 2009, 29(8): 1444-1453.
|
| 24 |
Wong GK, Chan DY, Siu DY, et al. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial [J]. Stroke, 2015, 46(2): 382-388.
|
| 25 |
Wong GK, Chan DY, Siu DY, et al. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial [J]. Stroke, 2015, 46(2): 382-388.
|
| 26 |
Macdonald RL. Are statins to be STASHed in subarachnoid haemorrhage? [J]. Lancet Neurol, 2014, 13(7): 639-641.
|
| 27 |
Kirkpatrick PJ, Turner CL, Smith C, et al. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial [J]. Lancet Neurol, 2014, 13(7): 666-675.
|
| 28 |
Grasso G, Tomasello G, Noto M, et al. Erythropoietin for the treatment of subarachnoid hemorrhage: a feasible ingredient for a successful medical recipe [J]. Mol Med, 2015, 21(1): 979-987.
|
| 29 |
Grasso G, Tomasello F. Erythropoietin for subarachnoid hemorrhage: is there a reason for hope? [J]. World Neurosurg, 2012, 1(77): 46-48.
|
| 30 |
Helbok R, Shaker E, Beer R, et al. High dose erythropoietin increases brain tissue oxygen tension in severe vasospasm after subarachnoid hemorrhage [J]. BMC neurol, 2012, 12(1): 32.
|
| 31 |
Tseng MY, Hutchinson PJ, Richards HK, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial [J]. J Neurosurg, 2009, 111(1): 171-180.
|
| 32 |
Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion [J]. Lancet, 2005, 366(9488): 809-817.
|
| 33 |
Ruan C, Long H, Sun H, et al. Endovascular coiling vs. surgical clipping for unruptured intracranial aneurysm: a meta-analysis [J]. Br J Neurosurg, 2015, 29(4): 485-492.
|
| 34 |
Tomatis A, Trevisi G, Boido B, et al. Surgical outcomes and their correlation to increasing surgical experience in a series of 250 ruptured or unruptured aneurysm undergoing microsurgical clipping [J]. World Neurosurgery, 2019, 130: e542-e550.
|